Extramedullary plasmacytoma with a t(11;14)(q13;q32) and aggressive clinical course

被引：2
|
作者：
Parkins, Elizabeth [2 ]
Boll, Maayke [1 ]
O'Connor, Sheila J. M. [1 ]
Rawstron, Andy C. [1 ]
Owen, Roger G. [1 ]
机构：
[1] Leeds Teaching Hosp NHS Trust, HMDS Lab, Leeds, W Yorkshire, England
[2] Royal Cornwall Hosp NHS Trust, Truro, England
来源：
LEUKEMIA & LYMPHOMA | 2010年 / 51卷 / 07期
关键词：
MULTIPLE-MYELOMA; NETWORK;
D O I：
10.3109/10428194.2010.486454
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1360 / 1362
页数：3
相关论文
共 50 条
  • [31] Overexpression of the PRAD1 oncogene in a patient with prolymphocytic leukemia with t(11;14)(q13;q32)
    Kobayashi, H
    Kitano, K
    Saito, H
    Aoki, K
    Narita, A
    Terada, N
    Sonoyama, M
    Uchimaru, K
    Machii, T
    Motokura, T
    CANCER GENETICS AND CYTOGENETICS, 1995, 84 (01) : 69 - 72
  • [32] Frequent allelic loss of the BCL10 gene in lymphomas with the t(11;14)(q13;q32)
    D Steinemann
    R Siebert
    S Harder
    I Martin-Subero
    G Kettwig
    B Hinzmann
    S Gesk
    M Tiemann
    H Merz
    A Rosenthal
    W Grote
    SW Morris
    B Schlegelberger
    Leukemia, 2001, 15 : 474 - 475
  • [33] Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants
    Avet-Loiseau, H
    Garand, R
    Lodé, L
    Harousseau, JL
    Bataille, R
    BLOOD, 2003, 101 (04) : 1570 - 1571
  • [34] Frequent allelic loss of the BCL10 gene in lymphomas with the t(11;14)(q13;q32)
    Steinemann, D
    Siebert, R
    Harder, S
    Martin-Subero, I
    Kettwig, G
    Hinzmann, B
    Gesk, S
    Tiemann, M
    Merz, H
    Rosenthal, A
    Grote, W
    Morris, SW
    Schlegelberger, B
    LEUKEMIA, 2001, 15 (03) : 474 - 475
  • [35] TPA stimulation culture for improved detection of t(11;14)(q13;q32) in mantle cell lymphoma
    Barouk-Simonet, E
    Andrieux, J
    Copin, MC
    Grardel-Duflos, N
    Huyghe, P
    Patte, JH
    Preudhomme, C
    Quesnel, B
    Laï, JL
    ANNALES DE GENETIQUE, 2002, 45 (03): : 165 - 168
  • [36] Overexpression of the PRAD1 oncogene in a patient with multiple myeloma and t(11;14)(q13;q32)
    Kobayashi, H
    Saito, H
    Kitano, K
    Kiyosawa, K
    Gaun, S
    Aoki, K
    Narita, A
    Watanabe, M
    Uchimaru, K
    Motokura, T
    ACTA HAEMATOLOGICA, 1995, 94 (04) : 199 - 203
  • [37] Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization
    Li, JY
    Gaillard, F
    Moreau, A
    Harousseau, JL
    Laboisse, C
    Milpied, N
    Bataille, R
    Avet-Loiseau, H
    AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (05): : 1449 - 1452
  • [38] Impact of t(11;14)(q13;q32) on the Outcome of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma
    Sasaki, Koji
    Lu, Gary
    Saliba, Rima M.
    Bashir, Qaiser
    Hosing, Chitra
    Popat, Uday
    Shah, Nina
    Parmar, Simrit
    Dinh, Yvonne
    Ahmed, Sairah
    Shpall, Elizabeth J.
    Kebriaei, Partow
    Shah, Jatin J.
    Orlowski, Robert Z.
    Champlin, Richard
    Qazilbash, Muzaffar H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (08) : 1227 - 1232
  • [39] The (11;14)(q13;q32) translocation in multiple myeloma (MM): A morphologic and immunohistochemical study
    Hoyer, JD
    Fonseca, R
    Greipp, PR
    Hanson, CA
    Kurtin, PJ
    LABORATORY INVESTIGATION, 1999, 79 (01) : 139A - 139A
  • [40] Mantle cell lymphoma/leukemia lacking evidence of t(11;14)(q13;q32): Is it a new disease entity?
    Woo, HY
    Nam, MH
    Park, Q
    Kim, SH
    Ko, YH
    Ree, HJ
    Kim, WS
    Lee, HG
    Park, KC
    BLOOD, 2001, 98 (11) : 237B - 237B
12345